NDC 81033-412-15 - Potassium Chloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 81033-412
- Requested NDC
- 81033-412-15
- Package NDCs from labels
- 81033-412-15, 81033-412-51, 81033-412-50, 81033-412-30, 81033-412-32, 81033-412-34
- Manufacturer
- Kesin Pharma
- Effective date
- 2024-12-04
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Potassium Chloride - Kesin Pharma | Kesin Pharma | 2024-12-04 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 81033-412-15 | Potassium Chloride | 15 mL in 1 CUP, UNIT-DOSE | SOLUTION | 15 | 5 | |
| 81033-412-30 | Potassium Chloride | 30 mL in 1 CUP, UNIT-DOSE | SOLUTION | 30 | 5 | |
| 81033-412-32 | Potassium Chloride | 100 in 1 CASE | SOLUTION | 100 | 5 | |
| 81033-412-34 | Potassium Chloride | 50 in 1 CASE | SOLUTION | 50 | 5 | |
| 81033-412-50 | Potassium Chloride | 100 in 1 CASE | SOLUTION | 100 | 5 | |
| 81033-412-51 | Potassium Chloride | 50 in 1 CASE | SOLUTION | 50 | 5 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 81033-412-15 | ML - Milliliter | 81033-412 | bbfbf218-c6fa-4f1f-a0b0-fd6c48577135 | 1 | 2024-08-12 |
| 81033-412-30 | ML - Milliliter | 81033-412 | b5400981-8240-485c-9d9f-87593850377e | 1 | 2024-08-12 |
| 81033-412-32 | ML - Milliliter | 81033-412 | 1d5cbd7d-98e5-4435-a285-be3bbff8b14a | 1 | 2024-08-12 |
| 81033-412-34 | ML - Milliliter | 81033-412 | ee33d2e1-7700-4f90-a7b5-9808c406891d | 1 | 2024-09-09 |
| 81033-412-50 | ML - Milliliter | 81033-412 | 3ec55d88-9e5c-430c-a4e9-fd74b75400de | 1 | 2024-08-12 |
| 81033-412-51 | ML - Milliliter | 81033-412 | a4c9fc82-8b5d-4db7-8def-ac8c2c3d5a44 | 1 | 2024-08-12 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Kali Muriaticum | KALI MURIATICUM | Hahnemann Laboratories, INC. | e3c8e13d-a67d-162c-e053-2a95a90abd11 | 2022-07-14 | 660YQ98I10 | |
| Glycerinum | GLYCERINUM | Hahnemann Laboratories, INC. | e34f8796-85b5-2946-e053-2995a90a251e | 2022-07-08 | PDC6A3C0OX | |
| KALIUM MURIATICUM 6X | POTASSIUM CHLORIDE | Seroyal USA | 22c95b6a-dd5d-476e-e054-00144ff8d46c | 2022-07-07 | Warnings | 660YQ98I10 |
| REFRESH Optive Mega-3 | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80 | Allergan, Inc. | c5f2b3f2-2071-45bd-a010-67f848bc0233 | 2022-06-30 | Warnings | PDC6A3C0OX |
| Sterile Water | WATER | Fresenius Kabi USA, LLC | f42ac50f-0ec5-4713-a4c8-99d972d90bed | 2022-06-22 | Warnings, Adverse reactions | 059QF0KO0R |
| Sterile Water | WATER | Fresenius Kabi USA, LLC | e71c6c83-d518-496c-b2ab-efd5987e4783 | 2022-06-09 | Warnings, Adverse reactions | 059QF0KO0R |
| Cardioplegic Solution | POTASSIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE, AND MAGNESIUM CHLORIDE | Fresenius Kabi, USA, LLC | eb360dc4-88d6-4b28-9b61-bc359e16bd22 | 2022-05-27 | Warnings, Adverse reactions | 660YQ98I10 |
| ACD Blood-Pack Units (PL 146 PLASTIC) | ANTICOAGULANT CITRATE DEXTROSE (ACD) | Fenwal, Inc. | ba894daa-688e-4a9e-bd74-e71797f951bb | 2022-04-27 | XF417D3PSL B22547B95K | |
| Miracle FootCream Lavender | UREA, GLYCERIN, ALOE, DISODIUM EDTA | Aloe Vera Korea Co.,Ltd. | db520c80-2a2a-5eb1-e053-2995a90a5bb4 | 2022-03-28 | Warnings | PDC6A3C0OX |
| Miracle FootCream Lemon | UREA, GLYCERIN, ALOE, DISODIUM EDTA | Aloe Vera Korea Co.,Ltd. | db525c63-29fd-2033-e053-2995a90a56b9 | 2022-03-28 | Warnings | PDC6A3C0OX |
| ALPHA SH | SANGUINARIA CANADENSIS ROOT, GOLDENSEAL, SILICON DIOXIDE, POTASSIUM CHLORIDE, PULSATILLA VULGARIS | Schwabe Mexico, S.A. de C.V. | 3e2e5f52-db54-4635-83a8-a67a683c093c | 2022-03-22 | Warnings | 660YQ98I10 |
| ALPHA SH | SANGUINARIA CANADENSIS ROOT, GOLDENSEAL, SILICON DIOXIDE, POTASSIUM CHLORIDE, PULSATILLA VULGARIS | Schwabe North America, Inc. | 94de9ce3-6ee9-4322-bda2-0b4391f09d87 | 2022-03-22 | Warnings | 660YQ98I10 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | B. Braun Medical Inc. | ab67b151-8368-4321-b562-bad5eff7b740 | 2022-02-21 | Warnings, Adverse reactions | 660YQ98I10 |
| Sodium Citrate Blood-Pack Units, (PL 146 Plastic) | ANTICOAGULANT SODIUM CITRATE SOLUTION | Fenwal, Inc. | a63da38d-1fea-4ee0-a70b-55c891a5ebcc | 2022-02-11 | B22547B95K | |
| Sodium Citrate Blood-Pack Units, (PL 146 Plastic) | ANTICOAGULANT SODIUM CITRATE SOLUTION | Fenwal, Inc. | ac8971a9-36d0-43c9-9121-ba5e58c28bed | 2022-02-11 | B22547B95K | |
| ACD-A | ANTICOAGULANT CITRATE DEXTROSE SOLUTION FORMULA A | Fenwal, Inc. | 22805f0d-ba58-41ea-b245-19980abcda22 | 2022-02-11 | XF417D3PSL | |
| Sterile Water | WATER | American Regent, Inc. | 78b35864-4bbc-4759-a5c1-7e4f25e22932 | 2022-01-31 | Boxed warning | 059QF0KO0R |
| Potassium Chloride | POTASSIUM CHLORIDE | Tris Pharma Inc | 159ddd0b-847e-4ecc-b3b2-9634cbb4dfa9 | 2022-01-26 | Warnings, Adverse reactions | 314182 312515 660YQ98I10 |
| Schusslers Immune | ECHINACEA, FERRUM PHOSPHORICUM, KALI MURIATICUM, ZINCUM GLUCONICUM | Nartex Laboratorios Homeopaticos, S.A. de C.V. | d46a3ac3-a37a-743d-e053-2a95a90ab0b1 | 2022-01-13 | Warnings | 660YQ98I10 |
| EAR RX | ACONITUM NAP, BARYTA CARB, BELLADONNA, CALC CARB, CAPSICUM, CARBO VEG, CAUSTICUM, CHAMOMILLA, FERRUM PHOS, HEPAR SULPH CALC, KALI MUR, LACHESIS, LYCOPODIUM, MERCURIUS SOL, NATRUM MUR, PLANTAGO, PULSATILLA, SILICEA, SULPHUR, VERBASCUM | Miami Beach Pediatrics pa | a8753f88-4b8a-472f-a4bd-f2e9cec83610 | 2021-12-29 | Warnings | 660YQ98I10 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.